Company / Assets per Share
Cardiff Oncology, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.93
FY2025
5-year range
$0.93 / $4.07
FY2021-FY2025
Trend
-57.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.40 in FY2017 to $19.33 in FY2018.
Based on SEC 10-K filings.
0.93 in FY2025 with a 5-year CAGR of -43.2%.
Declined from $1.83 to $0.93 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -43.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 57.2% year-over-year.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.93 | -57.2% |
| FY2024 | $2.18 | +19.1% |
| FY2023 | $1.83 | -34.0% |
| FY2022 | $2.77 | -31.9% |
| FY2021 | $4.07 | -74.1% |
| FY2020 | $15.68 | +359.1% |
| FY2019 | $3.42 | -82.3% |
| FY2018 | $19.33 | +4729.9% |
| FY2017 | $0.40 | -72.9% |
| FY2016 | $1.48 | -60.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026